Use careArticle link

Navigating Clinical Trial Recruitment and Making Informed Research Decisions

Clinical trials are essential for advancing Alzheimer's treatments, but recruitment is often slow and confusing for families. This article explains why it's hard to find and join studies, and gives you concrete steps to make informed decisions about participation. You'll learn what to ask, how to find trials that fit your situation, and how to protect your loved one's rights while contributing to research that could help future generations.

Key points

  • Clinical trial recruitment is hard because of travel requirements, strict eligibility criteria, and the need for enough participants with specific diagnoses.
  • Informed consent is a legal and ethical protection that requires researchers to explain risks, benefits, procedures, and alternatives in plain language.
  • Use the Alzheimer's Association TrialMatch tool to find studies near you or that offer remote participation.
  • Always ask about remote or decentralized options—many studies now allow some visits from home.
  • Involve your loved one in the decision if they can participate, and respect their wishes.
  • Keep a notebook of all study contacts, appointments, and observations to stay organized and help researchers.
  • Discuss the trial with your loved one's regular doctor before enrolling to check for safety and fit.

Why Clinical Trial Recruitment Is So Challenging

Clinical trials struggle to enroll enough participants because of several practical barriers. First, most studies require people to live near a specific research center and travel there regularly—sometimes every month for tests and treatments. This immediately excludes anyone who can't easily travel or who lives far from major medical centers. As one expert noted, 'How many people live around certain places? How many people are able to travel? It really makes it difficult.' For rare conditions like some forms of dementia, you need enough people to even run a trial before the FDA will consider it, which narrows the pool even further.

What Makes Informed Consent Different in Dementia Research

Informed consent is a critical protection for anyone considering a clinical trial. The FDA requires that researchers explain that the study involves research, how long participation will last, what procedures will be done, and which treatments are experimental. They must also describe reasonably anticipated risks, possible benefits, and alternatives. For people with dementia, this process takes extra care. Researchers need to spend more time in discussion to learn the participant's medical, family, social, and occupational history. They must think about the sensitivities and limitations of the tests they use. One researcher explained that 'the really good diagnosticians do not simply check off boxes on a list'—they talk through results with participants, which helps both sides learn.

Why People Choose to Participate—and Why They Hesitate

Many people with dementia want their experience to make a difference. As one advocate put it, 'I would like this to actually make a difference that I live through this. I really would like there to be a difference moving forward. I want to contribute in some way.' This sense of purpose drives many to join trials. But hesitation is common too. Some worry about being in early testing phases where the treatment is unproven. One person said, 'I would take the vaccine but I would not be willing to be in the trials for the vaccine' because they trust the final product more than the experimental stage. Others fear the unknown—what if the treatment has side effects? What if they get a placebo? These are valid concerns that good research teams will address openly.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Search for trials using the Alzheimer's Association TrialMatch tool (alz.org/trialmatch), filtering by diagnosis, stage, and location; note that some studies allow remote participation.

  2. Before contacting any team, gather your loved one's recent medical records (diagnoses, current medications, MRI/PET results) as researchers need these to assess eligibility.

  3. Request a phone or video pre-screening with the research coordinator, during which they can explain the study's risks and benefits before you travel.

  4. During that call, ask and write down: the study's purpose, which procedures are experimental versus standard care, the trial duration, known risks and side effects, placebo chance, and whether remote visits or local labs are available.

  5. Ask for the informed consent document to review at home before signing; confirm it includes the FDA-required elements (research nature, duration, all procedures, experimental treatments, risks, potential benefits, and alternatives) and ask the team to clarify anything unclear.

  6. Discuss the trial with your loved one's regular doctor, specifically whether the study is appropriate given other health conditions, whether current medications could interact with the experimental treatment, and whether the time and travel demands are realistic.

  7. If your loved one is in the early stage and can still decide, include them using simple language (e.g., 'This is a research study. They want to test a new medicine. You might get the medicine or a placebo. We would go to the hospital once a month. What do you think?') and respect their answer even if it is no.

  8. Once enrolled, keep a dedicated notebook with the study name, coordinator contact details, appointment dates, and any observed symptoms or changes between visits; report anything unusual to the research team promptly.

What not to do

  • Don't assume a trial is safe just because it appears on a reputable website; ask the coordinator whether the study has an Institutional Review Board (IRB) with independent members.

  • Don't rush into a decision due to desperation; allow at least a week to read the consent form, consult with your loved one's doctor, and ensure you understand the risks and time commitment.

  • Don't hide or minimize your loved one's symptoms or health conditions to qualify; the research team needs the full picture to determine safety and fit.

  • Don't forget to ask what happens when the trial ends—specifically, whether your loved one can continue receiving the treatment if it proves effective, and how the team will help transition back to your regular neurologist or primary care doctor.

  • Don't sign anything until you understand who covers medical costs if your loved one is injured during the study; in most trials, the sponsor covers such costs, not you or your insurance.

Practical tools

  • Alzheimer's Association TrialMatch

    A free service at alz.org/trialmatch that matches you to Alzheimer's and dementia trials based on diagnosis, stage, and zip code; allows filtering by travel willingness and provides direct coordinator contact information.

  • ClinicalTrials.gov

    The official US government database of all clinical trials; search by condition, location, and status. More comprehensive than TrialMatch but less curated, useful as a backup.

  • Informed Consent Question Checklist

    Before signing a consent form, ask and record answers to: (1) Is this research or standard treatment? (2) How long will participation last? (3) Which procedures are experimental? (4) What are the anticipated risks and discomforts? (5) What are the possible direct benefits? (6) What alternatives exist? (7) Can we withdraw at any time? (8) Who do we contact with problems or questions?

  • Study Participation Notebook

    A notebook or digital document to record the study name, coordinator contact, appointment dates, any observed symptoms or side effects, questions between visits, and a running medication log; bring it to every visit to keep organized and provide clear information to the research team.

Discuss with your clinician

Ask your loved one's primary doctor: 'Is this clinical trial safe given their other health conditions and medications? Are there any known drug interactions we should worry about?'

Ask the study doctor: 'What are the specific risks of this experimental treatment? How will you monitor for side effects? What is the plan if my loved one has a serious adverse event?'

Ask about the placebo: 'What percentage of participants get the placebo? Will we be told at the end which group we were in? If they get the placebo, can they cross over to the treatment group later?'

Ask about insurance and costs: 'Does my insurance cover any of the costs? What costs are covered by the study? Is there compensation for travel or time? What happens if my loved one is injured during the study?'

Ask about the end of the study: 'What happens when the trial ends? Will we still have access to the treatment if it's effective? How will we transition back to regular care?'

Related guides

Sources